Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Infrequent loss of luminal differentiation in ductal breast cancer metastasis.

Calvo J, Sánchez-Cid L, Muñoz M, Lozano JJ, Thomson TM, Fernández PL.

PLoS One. 2013 Oct 21;8(10):e78097. doi: 10.1371/journal.pone.0078097. eCollection 2013.

2.

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.

Cimino-Mathews A, Subhawong AP, Illei PB, Sharma R, Halushka MK, Vang R, Fetting JH, Park BH, Argani P.

Hum Pathol. 2013 Jul;44(7):1341-9. doi: 10.1016/j.humpath.2012.11.003. Epub 2013 Jan 31.

3.

[Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].

Li Q, Xu BH, Zhang P, Li Q, Yuan P, Wang JY, Luo Y, Ma F, Fan Y, Li Q.

Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):207-11. doi: 10.3760/cma.j.issn.0253-3766.2013.03.010. Chinese.

PMID:
23880002
5.

[Expression and clinical significance of LRP16 gene in human breast cancer].

Liao DX, Han WD, Zhao YL, Pu YD, Mu YM, Luo CH, Li XH.

Ai Zheng. 2006 Jul;25(7):866-70. Chinese.

PMID:
16831279
6.

Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.

Shahi KS, Bhandari G, Singh A.

J Cancer Res Ther. 2011 Jan-Mar;7(1):19-22. doi: 10.4103/0973-1482.80433.

7.

Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer.

van Agthoven T, Timmermans M, Dorssers LC, Henzen-Logmans SC.

Int J Cancer. 1995 Dec 11;63(6):790-3.

PMID:
8847135
8.

Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.

Jeschke U, Mylonas I, Kuhn C, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.

Anticancer Res. 2007 Jul-Aug;27(4A):1969-74.

9.

Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.

D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL.

Breast Cancer Res Treat. 2007 Mar;101(3):279-84. Epub 2006 Jul 12.

PMID:
16835704
10.

Elevated expression of both MDR1 and MMP-2 genes in metastasized lymph node of invasive ductal breast cancer.

Lu LS, Chen L, Ding WX, Li K, Wu JJ.

Eur Rev Med Pharmacol Sci. 2012 Dec;16(15):2037-43.

12.

Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer.

Li X, Cao X, Li X, Zhang W, Feng Y.

Cancer Sci. 2007 Oct;98(10):1592-6. Epub 2007 Jul 25.

13.

Hormone receptors and HER2 expression in primary breast carcinoma and corresponding lymph node metastasis: do we need both?

Raica M, Cîmpean AM, Ceausu RA, Fulga V, Nica C, Rudico L, Saptefrati L.

Anticancer Res. 2014 Mar;34(3):1435-40.

PMID:
24596391
14.

The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.

Popiela TJ, Sikora J, Klimek M, Basta P, Niemiec T, Dobrogowski J, Kotlarz A, Rudnicka-Sosin L, Dutsch-Wicherek M.

Neuro Endocrinol Lett. 2008 Aug;29(4):443-6.

PMID:
18766141
15.

Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?

Falck AK, Fernö M, Bendahl PO, Rydén L.

World J Surg. 2010 Jul;34(7):1434-41. doi: 10.1007/s00268-010-0499-z.

PMID:
20213203
16.

The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.

Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaoka S, Koyama H.

Cancer. 1994 Sep 1;74(5):1595-600.

17.

A mouse model for luminal epithelial like ER positive subtype of human breast cancer.

Kumar MJ, Ponvijay KS, Nandhini R, Nagarajan RS, Jose J, Srinivas G, Nagarajan P, Venkatesan R, Kumar K, Singh S.

BMC Cancer. 2007 Sep 20;7:180.

18.

Tumor-associated overexpression of the soluble T1-S receptor in lymph node-negative breast cancer.

Werenskiold AK, Prechtel D, Harbeck N, Höfler H.

Diagn Mol Pathol. 2000 Mar;9(1):26-34.

PMID:
10718210
19.

Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.

St Romain P, Madan R, Tawfik OW, Damjanov I, Fan F.

Hum Pathol. 2012 Mar;43(3):398-404. doi: 10.1016/j.humpath.2011.05.009. Epub 2011 Aug 12.

PMID:
21840040
20.

Expression of 6 common antigenic markers in invasive ductal breast carcinoma: potential clinical implications.

Lialiaris TS, Kouskoukis A, Georgiou G, Tripsianis G, Fiska A, Giatromanolaki A, Chrisafi S, Sivridis E, Vamvakopoulou DN, Soutopoulou DO, Kiritsaka A, Athanassiou E, Lialios GA, Sotiriou S, Sidiropoulos A, Vamvakopoulos NC.

Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):106-11. doi: 10.1097/PAI.0b013e3181e181b1.

PMID:
20724920

Supplemental Content

Support Center